Organization
UT Southwestern Medical Center, Dallas, United States
2 abstracts
Abstract
A RANDOMIZED, DOUBLE-BLIND, PHASE 1 STUDY DEMONSTRATES EQUIVALENCE IN PHARMACOKINETICS, SAFETY, AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS Org: Inha University Hospital, Incheon, Korea, Republic Of, Prywatna Praktyka Lekarska Reumatologiczno-Immunologiczna, Poznań, Poland, National Scientific Center, Kiev, Ukraine, Centro de Estudios Reumatolόgicos, Santiago, Chile, Antiguo Hospital Civil de Guadalajara, Guadalajara, Mexico,
Abstract
A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 1 STUDY COMPARING THE PHARMACOKINETICS, SAFETY AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 54 WEEK RESULTS FROM THE PLANETAS STUDY Org: Inha Univ. Hospital, Incheon, Korea, Republic Of, Linea Corporis, Warszawa, Wojewodzki Szpital Zespolony w Elblagu, Elbląg, Poland, Institute of Urgent and Recovery Surgery, Donetsk, Ukraine, Univ. Hospital St. Marina, Varna, Bulgaria,